Endo International Ordinary Shares reported $-1885427000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Amarin AMRN:US $ -69.96M 38.39M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eli Lilly And LLY:US $ 952.5M 950.4M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Hikma Pharmaceutical HIK:LN 173M 0
Horizon Pharma HZNP:US $ 60.97M 143.29M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Lannett LCI:US $ -34.9M 46.19M
Merk MRK:US $ 3944M 366M
Novartis NOVN:VX SF 1694M 528M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Perrigo Ordinary Shares PRGO:US $ -65.1M 62.7M
Pfizer PFE:US $ 9905M 2042M
Phibro Animal Health PAHC:US $ 17.69M 0.22M
Revance Therapeutics RVNC:US $ -61.44M 2.91M
Supernus Pharmaceuticals SUPN:US $ 7.86M 17.75M
Takeda 4502:JP Y 105014M 116372M
Teva Pharmaceutical TEVA:IT -233000000 722M
Zoetis ZTS:US $ 529M 66M